LON:PEBIPort Erin Biopharma Investments Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Port Erin Biopharma Investments Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume7,434 shsMarket Capitalization£1.04 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartHeadlines Port Erin Biopharma Investments Limited is a principal investment firm specializing in investments in equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Port Erin Biopharma Investments Limited was founded on May 3, 2011 and is based in Isle of Man, United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Port Erin Biopharma Investments. Previous Next 2.5 Community Rank Outperform VotesPort Erin Biopharma Investments has received 60 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPort Erin Biopharma Investments has received 58 “underperform” votes. (Add your “underperform” vote.)Community SentimentPort Erin Biopharma Investments has received 50.85% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Port Erin Biopharma Investments and other stocks. Vote “Outperform” if you believe PEBI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PEBI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPort Erin Biopharma Investments does not currently pay a dividend.Dividend GrowthPort Erin Biopharma Investments does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Port Erin Biopharma Investments insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Port Erin Biopharma Investments is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Port Erin Biopharma Investments is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:PEBI Previous Symbol CUSIPN/A CIKN/A Webhttp://www.porterinbiopharma.com/ Phone+44-1624-620711Debt Debt-to-Equity RatioN/A Current Ratio59.77 Quick Ratio59.77Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£28,300.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.55 Book ValueGBX 8.10 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares23,195,600Market Cap£1.04 million Next Earnings DateN/A OptionableNot Optionable Receive PEBI News and Ratings via Email Sign-up to receive the latest news and ratings for PEBI and its competitors with MarketBeat's FREE daily newsletter. LSE:PEBI Rates by TradingView Port Erin Biopharma Investments (LON:PEBI) Frequently Asked Questions Has Port Erin Biopharma Investments been receiving favorable news coverage? Press coverage about PEBI stock has been trending very negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Port Erin Biopharma Investments earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutPort Erin Biopharma Investments. Who are some of Port Erin Biopharma Investments' key competitors? Some companies that are related to Port Erin Biopharma Investments include Factor Therapeutics (FTT), Revive Therapeutics (RVV), IBEX Technologies (IBT), Amplia Therapeutics (ATX), BPH Energy (BPH), Netscientific (NSCI), SalvaRx Group (SALV), Cotinga Pharmaceuticals (COT), Pacgen Life Science (PBS), Physiomics (PYC), ImmunoCellular Therapeutics (IMUC), Medifocus (MFS), ValiRx (VAL), AngioSoma (SOAN) and Motif Bio (MTFB). Who are Port Erin Biopharma Investments' key executives? Port Erin Biopharma Investments' management team includes the following people: Mr. Denham Hervey Newall Eke, CFO, Fin. Director & Director (Age 67) What is Port Erin Biopharma Investments' stock symbol? Port Erin Biopharma Investments trades on the London Stock Exchange (LON) under the ticker symbol "PEBI." How do I buy shares of Port Erin Biopharma Investments? Shares of PEBI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. How big of a company is Port Erin Biopharma Investments? Port Erin Biopharma Investments has a market capitalization of £0.00 and generates £28,300.00 in revenue each year. View additional information about Port Erin Biopharma Investments. What is Port Erin Biopharma Investments' official website? The official website for Port Erin Biopharma Investments is http://www.porterinbiopharma.com/. How can I contact Port Erin Biopharma Investments? Port Erin Biopharma Investments' mailing address is 18 Athol Street, DOUGLAS, IM1 1JA, Isle of Man. The company can be reached via phone at +44-1624-620711. This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: Diversification in Investing
